drugset / Trial / NCT01984580

Effect of Zinc on Barrett's Metaplasia

NCT01984580

RandomizedParallel-groupSingle-blindPrevention

Summary

Using orally administered zinc to patients already diagnosed with the pre-cancerous condition, Barrett's Esophagus, this study is asking two questions: 1. can this zinc administration cause molecular-level changes in the Barrett's tissue? 2. are the changes measured indicative of chemopreventive action by zinc regarding cancer progression?

Timeline

Start
2011-04
Primary completion
2015-03
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc gluconate Small molecule 26.6 mg Oral

Indications